Packaging
BIOMEDevice Europe 2010
Tuesday 28. July 2009 - First European event dedicated to the booming market of the new generation of combination products; where pharmaceutical, biotechnology and medical device industries converge
Co-located with the 9th edition of Pharmapack , the BIOMEDevice Europe conference and exhibition will take place in Paris, France, February 1-2, 2010.
The development of new combination products is regarded today as one of the most promising fields in terms of market opportunities for a large number of health products, notably in Cardiovascular, Orthopaedic and Wound care technology. According to analysts, the combination products market, which represents currently 8 billions euros, will grow by 40% over the next 3 years. In addition to extending the product life of existing pharmaceutical brands, combination devices allow for delivering drugs locally to maximise therapeutic effect while minimising contraindications.
As the first European event dedicated to combination products, BIOMEDevice Europe brings together all the professionals from leading biotechnology, medical device and pharmaceutical companies involved in this sector. Thus, it offers a perfect networking platform to key executives, engineers and researchers looking for new partnering and enabling technologies for the future development of combination products. BIOMEDevice Europe visitors and delegates profile covers a wide range of jobs functions, among which are senior executives, device/drug delivery system design engineers and development managers purchasing/sourcing managers, project and business managers, finance and legal executives.
During the BIOMEDevice Europe two-day conference program, the most eminent experts in the development of combination products will provide an insight into the current market trends and opportunities. They will also address regulatory concerns, in connection to the legislative framework and procedures in Europe. Invaluable information will be given regarding licensing, investing and partnership strategy. The other subjects covered include: intellectual property strategy, pricing and reimbursement, new promising materials and enabling technologies to manufacture drug-device combination products.
Running in parallel with the conferences, the BIOMEDevice Europe and Pharmapack exhibition will match together over 200 leading players from the supply chain with key decision-makers from major medical device and pharmaceutical companies.